Page last updated: 2024-10-24

cadralazine and Chronic Disease

cadralazine has been researched along with Chronic Disease in 1 studies

cadralazine: structure given in first source

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gibelin, P1
Camous, JP1
Profit-Degoul, I1
Baudouy, M1
Morand, P1

Other Studies

1 other study available for cadralazine and Chronic Disease

ArticleYear
[Efficacy and tolerability of a delayed-action vasodilator agent, cadralazine, in severe chronic cardiac failure].
    Annales de cardiologie et d'angeiologie, 1986, Volume: 35, Issue:2

    Topics: Aged; Chronic Disease; Delayed-Action Preparations; Female; Heart Failure; Hemodynamics; Humans; Mal

1986